Results 141 to 150 of about 6,354,037 (297)
Quick Exchange, April 21, 1998 [PDF]
Office of Public Relations, Bryant College
core +1 more source
Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin +11 more
wiley +1 more source
Quick Exchange, February 24, 2000 [PDF]
Office of Public Relations, Bryant College
core +1 more source
ABSTRACT Just recently, successful chimeric antigen receptor (CAR) T cell therapy was reported in the first patient with refractory, anti‐diacylglycerol lipase alpha (DAGLA) antibody‐mediated autoimmune encephalitis, achieving partial clinical remission.
Dimitrios Mougiakakos +9 more
wiley +1 more source
Intraoperative Optical Coherence Tomography Features of Epiretinal Human Amniotic Membrane Graft Under Different Tamponade Agents. [PDF]
Antaki F, Thanos A, Mammo DA.
europepmc +1 more source
Quick Exchange, June 9, 2000 [PDF]
Office of Public Relations, Bryant College
core +1 more source
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy has been investigated in neurological diseases, encompassing both central nervous system malignancies and autoimmune disorders, thereby extending its application beyond hematological cancers.
Omar Alqaisi +5 more
wiley +1 more source
In Situ Insights into Enhanced Cooperative Ligand Exchange Kinetics via Solvent-Induced Restacking in a 2D Metal-Organic Framework. [PDF]
Engemann R +16 more
europepmc +1 more source

